CorRELation Between PatIent PErception and Findings on Clinical Examination
RELIEF
1 other identifier
observational
505
1 country
19
Brief Summary
This is a multi-center, prospective, non-interventional study that aims to evaluate in daily clinical practice, the possible corelation between patIent perception of the ability to perform morning activities and physician evaluation; patients with COPD, grade C and D.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2012
Shorter than P25 for all trials
19 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 22, 2012
CompletedFirst Posted
Study publicly available on registry
June 26, 2012
CompletedStudy Start
First participant enrolled
July 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2013
CompletedFebruary 21, 2013
February 1, 2013
6 months
June 22, 2012
February 20, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change from baseline in Capacity of Daily Living during the Morning (CDLM) Questionnaire
CDLM questionnaire is a simple self-reporting tool of the burden and ability of COPD patients to perform routine morning activities: washing, dressing, eating breakfast, walking around. For each of these morning activities the score is varying from 0 (indicating worst case) to 5 (indicating best case).
Baseline and 3 months
Change from baseline of patient's general health status based upon physician evaluation - visual scale
General health status visual scale is assessing the physicians perception of the patient health status following the clinical examination. Based upon clinical evaluation, the physician will indicate the patient's general condition on a a scale consisting of 5 levels. The scale will be completed at each visit and the score can vary from 1(very bad general health status) to 5 (very good general health status) .
Baseline and 3 months
Secondary Outcomes (4)
Demographic patient characteristics
Day 0 (visit1)
Patient adherence to treatment - visual scale
up to 3 months
Number of daily walking steps (using pedometer)
up to 3 months
Number of exacerbations
up to 3 months
Study Arms (1)
COPD patients grade C and D
Eligibility Criteria
COPD patients, group C and D according to GOLD guidelines 2011, being treated for at least 1 month with combination ICS/LABA treatment
You may qualify if:
- Diagnosis of COPD, grade C and D according to GOLD Guidelines Revised 2011
- Current or past smokers, of at least 10 pack years
- Receive any inhaled combination therapy for COPD (inhaled corticosteroid / long acting β2-agonist bronchodilator) initiated for at least one month before entering in the study
You may not qualify if:
- History of exacerbation of COPD symptoms within the last month before visit 1, inclusive; history of asthma or allergic rhinitis; history of lung carcinoma or any other respiratory condition that may limit the airflow circulation
- Inability to understand study procedures and inability/refuse to complete CDLM questionnaires and/or record the values showed on the pedometer screen
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AstraZenecalead
Study Sites (19)
Research Site
Bacau, Romania
Research Site
Botoșani, Romania
Research Site
Bucharest, Romania
Research Site
Buzău, Romania
Research Site
Călăraşi, Romania
Research Site
Cluj-Napoca, Romania
Research Site
Constanța, Romania
Research Site
Craiova, Romania
Research Site
Drobeta-Turnu Severin, Romania
Research Site
Fălticeni, Romania
Research Site
Focşani, Romania
Research Site
Iași, Romania
Research Site
Leordeni, Romania
Research Site
Luduş, Romania
Research Site
Oradea, Romania
Research Site
Ploieşti, Romania
Research Site
Râmnicu Vâlcea, Romania
Research Site
Reghin, Romania
Research Site
Slatina, Romania
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Florin Mihaltan, PROFESSOR
University of Medicine and Pharmacy Carol Davila, Bucharest, Romania
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 22, 2012
First Posted
June 26, 2012
Study Start
July 1, 2012
Primary Completion
January 1, 2013
Study Completion
January 1, 2013
Last Updated
February 21, 2013
Record last verified: 2013-02